• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Patterns and prognostic significance of cutaneous immune-related adverse events in non-small cell lung cancer.

作者信息

Thompson Leah L, Nadelmann Emily R, Blum Amy E, Yoon Jaewon, Polyakov Nicole J, Kagan Ruth D, Gainor Justin F, Mooradian Meghan J, Chen Steven T

机构信息

Department of Dermatology, Massachusetts General Hospital & Harvard Medical School, 50 Staniford Street, Boston MA 02114, USA.

Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA, USA.

出版信息

Eur J Cancer. 2021 Apr;147:13-16. doi: 10.1016/j.ejca.2021.01.022. Epub 2021 Feb 16.

DOI:10.1016/j.ejca.2021.01.022
PMID:33607381
Abstract
摘要

相似文献

1
Patterns and prognostic significance of cutaneous immune-related adverse events in non-small cell lung cancer.非小细胞肺癌皮肤免疫相关不良事件的模式及预后意义
Eur J Cancer. 2021 Apr;147:13-16. doi: 10.1016/j.ejca.2021.01.022. Epub 2021 Feb 16.
2
Thyroid function abnormality induced by PD-1 inhibitors have a positive impact on survival in patients with non-small cell lung cancer.PD-1 抑制剂引起的甲状腺功能异常对非小细胞肺癌患者的生存有积极影响。
Int Immunopharmacol. 2021 Feb;91:107296. doi: 10.1016/j.intimp.2020.107296. Epub 2020 Dec 23.
3
Effect of corticosteroids on the outcome of patients with advanced non-small cell lung cancer treated with immune-checkpoint inhibitors.皮质类固醇对免疫检查点抑制剂治疗晚期非小细胞肺癌患者结局的影响。
Eur J Cancer. 2021 Mar;145:245-254. doi: 10.1016/j.ejca.2020.12.012. Epub 2021 Jan 5.
4
Immune checkpoint inhibitor efficacy and safety in older non-small cell lung cancer patients.免疫检查点抑制剂在老年非小细胞肺癌患者中的疗效和安全性。
Jpn J Clin Oncol. 2020 Dec 16;50(12):1447-1453. doi: 10.1093/jjco/hyaa152.
5
Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapy.肿瘤浸润淋巴细胞密度与免疫治疗晚期非小细胞肺癌患者的良好预后相关。
Eur J Cancer. 2021 Mar;145:221-229. doi: 10.1016/j.ejca.2020.10.017. Epub 2021 Jan 27.
6
Pericarditis during chemoimmunotherapy for non-small cell lung cancer: an adverse event to prevent and recognise.非小细胞肺癌化疗免疫治疗期间的心包炎：一种需要预防和识别的不良事件。
Eur J Cancer. 2021 May;149:114-116. doi: 10.1016/j.ejca.2021.03.004. Epub 2021 Apr 12.
7
Efficacy and safety of combined immunotherapy and antiangiogenic therapy for advanced non-small cell lung cancer: A two-center retrospective study.联合免疫治疗和抗血管生成治疗晚期非小细胞肺癌的疗效和安全性：一项两中心回顾性研究。
Int Immunopharmacol. 2020 Dec;89(Pt A):107033. doi: 10.1016/j.intimp.2020.107033. Epub 2020 Oct 8.
8
Radiographic features and prognosis of early- and late-onset non-small cell lung cancer immune checkpoint inhibitor-related pneumonitis.早发性和晚发性非小细胞肺癌免疫检查点抑制剂相关肺炎的影像学特征和预后。
BMC Cancer. 2021 May 29;21(1):634. doi: 10.1186/s12885-021-08353-y.
9
A real-world data of Immune checkpoint inhibitors in solid tumors from India.印度实体瘤免疫检查点抑制剂的真实世界数据。
Cancer Med. 2021 Mar;10(5):1525-1534. doi: 10.1002/cam4.3617. Epub 2021 Feb 16.
10
Immune checkpoint inhibitor-associated interstitial lung diseases correlate with better prognosis in patients with advanced non-small-cell lung cancer.免疫检查点抑制剂相关的间质性肺疾病与晚期非小细胞肺癌患者的更好预后相关。
Thorac Cancer. 2020 Apr;11(4):1052-1060. doi: 10.1111/1759-7714.13364. Epub 2020 Feb 25.

引用本文的文献

1
Association of Cutaneous Immune-related Adverse Events with Overall Survival and Progression-free Survival in Oncology Patients Receiving Immune Checkpoint Inhibitors: A Prospective Study of 189 Patients in a Spanish Tertiary Care Hospital.接受免疫检查点抑制剂治疗的肿瘤患者皮肤免疫相关不良事件与总生存期和无进展生存期的关联：西班牙一家三级护理医院对189例患者的前瞻性研究
Acta Derm Venereol. 2025 Jan 3;105:adv42023. doi: 10.2340/actadv.v105.42023.
2
Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management.罕见的免疫相关不良事件（irAEs）：诊断和管理方法。
Pharmaceut Med. 2024 Jan;38(1):25-38. doi: 10.1007/s40290-023-00508-5. Epub 2024 Jan 9.
3
Diagnostic accuracy of general dermatologists and supportive oncodermatologists for biopsied cutaneous immune-related adverse events.
一般皮肤科医生和支持性肿瘤皮肤科医生对活检皮肤免疫相关不良事件的诊断准确性。
Support Care Cancer. 2022 Oct;30(10):7827-7831. doi: 10.1007/s00520-022-07233-w. Epub 2022 Jul 9.